Birmingham, West Midlands -- (SBWIRE) -- 01/24/2014 -- Value Penny Stocks issues special report on Groupon Inc (NASDAQ:GRPN), Himax Technologies, Inc. (ADR) (NASDAQ:HIMX), Staples, Inc. (NASDAQ:SPLS), Peregrine Pharmaceuticals (NASDAQ:PPHM).
Groupon Inc (NASDAQ:GRPN) ended its recent business day with the loss of -1.02% and closed at the price of $10.64 after opening at $10.70. The stock traded during its last trading session with the total volume of 9.11 million shares, as compared to its average volume of 17.97 million shares. Groupon, Inc. operates as a local commerce marketplace that connects merchants to consumers by offering goods and services at a discount in North America and internationally. The company also offers deals on products for which it acts as the merchant of record.
Has GRPN Found The Bottom and Ready To Move Up? Find Out Here
Himax Technologies, Inc. (ADR) (NASDAQ:HIMX) remained among the day decliners and traded with volume of 8.60 million shares in the last session, as compared to average volume of 8.66 million shares. In comparison with 52 week range of $2.58 - $15.33, it faced lowest price of $14.07 during the last trading session whereas its day highest price was $14.60. The company’s total market capitalization is $2.44 billion, along with 169.57 million shares outstanding. Himax Technologies, Inc. designs, develops, and markets semiconductors for flat panel displays. The company operates in two segments, Driver IC and Non-Driver Products. Its principal products include display drivers and timing controllers for large-sized thin film transistor liquid crystal display (TFT-LCD) panels that are used in desktop monitors, notebook computers, and televisions.
Has HIMX Found The Bottom And Ready To Gain Momentum? Find Out Here
Staples, Inc. (NASDAQ:SPLS) showed 8.55 million shares in volume during the last trading session, while the average trading volume remained 9.30 million shares. The stock kicked off its trading session at $13.70 and closed at $13.75 after declining -0.51%. Staples, Inc., together with its subsidiaries, operates as an office products company. It operates in three segments: North American Stores & Online, North American Commercial, and International Operations.
Why Should Investors Buy SPLS After the Recent Fall? Just Go Here and Find Out
Peregrine Pharmaceuticals (NASDAQ:PPHM) stock traded during its last trading session with the total traded volume of 8.32 million shares versus its average volume of 3.74 million shares. The company opened its trade at the price of $2.00 and its closing price was $1.91 after losing -4.98% for the day. Peregrine Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development of monoclonal antibodies focused on the treatment and diagnosis of cancer. The company’s lead product candidates in development include Bavituximab, a phosphatidylserine (PS) targeting agent that completed Phase IIb second-line non-small cell lung cancer trial for the treatment of solid tumors.
Will PPHM Get Buyers Even After The Recent Rally? Find Out Here
About Value Penny Stocks:
Value Penny Stocks was made by Two Active traders, Steve and Wilson, whom have made a platform for traders in order to provide traders the #1 Penny Stock Newsletter which actually gives value to your money and makes your portfolio full of profits. We concentrate on small cap stocks that trade on NYSE, NASD, AMEX, OTCBB, and OTC exchanges. These are usually stocks that will trade under $5 a share and offer the utmost potential profit on your short or long term investment. We also devote ourselves to understanding the overall market situations and use this knowledge in order to gain a better perception during our stock picking decisions.
We at ValuePennyStocks.com are engaged in the business of marketing and advertising companies. All content on our website is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities.
Please Read Our Full Disclaimer at: http://www.valuepennystocks.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)